Akut mieloid leukémia (AML): vizsgálatok itt: Puerto Rico

In Puerto Rico 10 Also abroad 761

10 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Where
San Juan
Életkor
18 év to 59 év
People
335 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT05554406
2. fázisTaking people
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Where
San Juan
Életkor
60 év and over
People
126 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07437950
2. fázisTaking people
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Where
San Juan
Életkor
18 év and over
People
147 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06317649
2. fázisTaking people
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
Where
San Juan
Életkor
18 év to 59 év
People
162 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06917911
2. fázisTaking people
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Where
San Juan
Életkor
18 év and over
People
2000 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT05564390
2. fázisTaking people
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Where
San Juan
Életkor
18 év to 59 év
People
153 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT05554393
2. fázisTaking people
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Where
San Juan
Életkor
18 év and over
People
93 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06672146
1/2. fázisTaking people
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Where
San Juan
Életkor
30 nap and over
People
447 worldwide
Run by
Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00
3. fázisTaking people
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Where
San Juan
Életkor
6 hónap to 21 év
People
1400 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT04293562
1/2. fázisTaking people
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Where
Caguas, San Juan
Életkor
Up to 22 év
People
960 worldwide
Run by
PedAL BCU, LLC
See details and how to joinNCT04726241